Drugs / paraldehyde
paraldehyde
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00116064 | Jul 2004 → Jun 2005 | epilepsy | Kamuzu University of Health Sciences | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | paraldehyde | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00116064 ↗ |
| Known as | 2,4,6-trimethyl-s-trioxane | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410743 ↗ |
| Known as | FEMA NO. 4010 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410743 ↗ |
| Known as | NSC-9799 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410743 ↗ |
| Known as | Paral | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410743 ↗ |
| Known as | Paraldehyde civ | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410743 ↗ |
| Modality | Small molecule | — CHEMBL1410743 ↗ |
| Route | Intramuscular | “intramuscular paraldehyde” NCT00116064 ↗ |